aluates Reports

$ 0.0

Automative

Global Dry Powder Inhalation Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-23K16694

Global Dry Powder Inhalation Capsules Market Research Report 2024

BUY CHAPTERS

Global Dry Powder Inhalation Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-23K16694

Report

November 2025

Pages:158

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Capsugel (Lonza)

ACG

Qualicaps

HealthCaps India

Cipla Ltd

Boehringer Ingelheim GmbH

ELPEN

Vectura Group plc

Chiesi Farmaceutici

Astrazeneca plc

Novartis

Dry Powder Inhalation Capsules Market Size

The global Dry Powder Inhalation Capsules market is projected to grow from US$ 891 million in 2024 to US$ 1364 million by 2031, at a CAGR of 6.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Dry Powder Inhalation Capsules Market

Inhalation capsules are a new and successful technique for directly delivering drugs to the respiratory system, providing a focused approach to treating a variety of respiratory disorders. These capsules, also known as dry powder inhalers (DPIs), have gained popularity in the field of respiratory medicine due to their ease of use, portability, and ability to provide immediate relief for people suffering from asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

One of the primary factors leading to inhalation capsules' adoption is their quick onset of action. Unlike oral drugs, which need to pass through the digestive system, inhalation permits the drug to be directly absorbed into the circulation via the respiratory system. This leads to faster therapeutic effects, making inhalation capsules especially useful in instances when a speedy reaction is required, such as emergency treatments or treating acute symptoms. Furthermore, inhalation capsules are ideal for elderly and pediatric patients since they avoid the difficulties associated with ingesting pills or tablets. Inhalation may be a more appealing and less threatening way for children to take medicines.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dry Powder Inhalation Capsules market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Dry Powder Inhalation Capsules Market Report

Report Metric	Details
Report Name	Dry Powder Inhalation Capsules Market
Accounted market size in 2024	US$ 891 million
Forecasted market size in 2031	US$ 1364 million
CAGR	6.4%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Gelatin Capsules Hypromellose Capsules
Segment by Application	Asthma Treatment COPD Management Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Capsugel (Lonza), ACG, Qualicaps, HealthCaps India, Cipla, Boehringer Ingelheim GmbH, Elpen S.A., Vectura Group Plc, CHIESI Farmaceutici S.p.A., AstraZeneca Plc, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Dry Powder Inhalation Capsules study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Dry Powder Inhalation Capsules Market growing?

Ans: The Dry Powder Inhalation Capsules Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Dry Powder Inhalation Capsules Market size in 2031?

Ans: The Dry Powder Inhalation Capsules Market size in 2031 will be US$ 1364 million.

Who are the main players in the Dry Powder Inhalation Capsules Market report?

Ans: The main players in the Dry Powder Inhalation Capsules Market are Capsugel (Lonza), ACG, Qualicaps, HealthCaps India, Cipla, Boehringer Ingelheim GmbH, Elpen S.A., Vectura Group Plc, CHIESI Farmaceutici S.p.A., AstraZeneca Plc, Novartis

What are the Application segmentation covered in the Dry Powder Inhalation Capsules Market report?

Ans: The Applications covered in the Dry Powder Inhalation Capsules Market report are Asthma Treatment, COPD Management, Others

What are the Type segmentation covered in the Dry Powder Inhalation Capsules Market report?

Ans: The Types covered in the Dry Powder Inhalation Capsules Market report are Gelatin Capsules, Hypromellose Capsules

1 Study Coverage

1.1 Introduction to Dry Powder Inhalation Capsules: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Dry Powder Inhalation Capsules Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Gelatin Capsules

1.2.3 Hypromellose Capsules

1.3 Market Segmentation by Application

1.3.1 Global Dry Powder Inhalation Capsules Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Asthma Treatment

1.3.3 COPD Management

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Dry Powder Inhalation Capsules Revenue Estimates and Forecasts 2020-2031

2.2 Global Dry Powder Inhalation Capsules Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Dry Powder Inhalation Capsules Sales Estimates and Forecasts 2020-2031

2.4 Global Dry Powder Inhalation Capsules Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Dry Powder Inhalation Capsules Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Dry Powder Inhalation Capsules Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Gelatin Capsules Market Size by Manufacturers

3.5.2 Hypromellose Capsules Market Size by Manufacturers

3.6 Global Dry Powder Inhalation Capsules Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Dry Powder Inhalation Capsules Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Dry Powder Inhalation Capsules Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Dry Powder Inhalation Capsules Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Dry Powder Inhalation Capsules Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Dry Powder Inhalation Capsules Sales and Revenue by Type (2020-2031)

6.4 North America Dry Powder Inhalation Capsules Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Dry Powder Inhalation Capsules Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Dry Powder Inhalation Capsules Sales and Revenue by Type (2020-2031)

7.4 Europe Dry Powder Inhalation Capsules Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Dry Powder Inhalation Capsules Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Dry Powder Inhalation Capsules Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Dry Powder Inhalation Capsules Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Dry Powder Inhalation Capsules Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Dry Powder Inhalation Capsules Sales and Revenue by Type (2020-2031)

9.4 Central and South America Dry Powder Inhalation Capsules Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Dry Powder Inhalation Capsules Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Dry Powder Inhalation Capsules Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Dry Powder Inhalation Capsules Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Dry Powder Inhalation Capsules Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Capsugel (Lonza)

11.1.1 Capsugel (Lonza) Corporation Information

11.1.2 Capsugel (Lonza) Business Overview

11.1.3 Capsugel (Lonza) Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.1.4 Capsugel (Lonza) Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Capsugel (Lonza) Dry Powder Inhalation Capsules Sales by Product in 2024

11.1.6 Capsugel (Lonza) Dry Powder Inhalation Capsules Sales by Application in 2024

11.1.7 Capsugel (Lonza) Dry Powder Inhalation Capsules Sales by Geographic Area in 2024

11.1.8 Capsugel (Lonza) Dry Powder Inhalation Capsules SWOT Analysis

11.1.9 Capsugel (Lonza) Recent Developments

11.2 ACG

11.2.1 ACG Corporation Information

11.2.2 ACG Business Overview

11.2.3 ACG Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.2.4 ACG Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 ACG Dry Powder Inhalation Capsules Sales by Product in 2024

11.2.6 ACG Dry Powder Inhalation Capsules Sales by Application in 2024

11.2.7 ACG Dry Powder Inhalation Capsules Sales by Geographic Area in 2024

11.2.8 ACG Dry Powder Inhalation Capsules SWOT Analysis

11.2.9 ACG Recent Developments

11.3 Qualicaps

11.3.1 Qualicaps Corporation Information

11.3.2 Qualicaps Business Overview

11.3.3 Qualicaps Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.3.4 Qualicaps Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Qualicaps Dry Powder Inhalation Capsules Sales by Product in 2024

11.3.6 Qualicaps Dry Powder Inhalation Capsules Sales by Application in 2024

11.3.7 Qualicaps Dry Powder Inhalation Capsules Sales by Geographic Area in 2024

11.3.8 Qualicaps Dry Powder Inhalation Capsules SWOT Analysis

11.3.9 Qualicaps Recent Developments

11.4 HealthCaps India

11.4.1 HealthCaps India Corporation Information

11.4.2 HealthCaps India Business Overview

11.4.3 HealthCaps India Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.4.4 HealthCaps India Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 HealthCaps India Dry Powder Inhalation Capsules Sales by Product in 2024

11.4.6 HealthCaps India Dry Powder Inhalation Capsules Sales by Application in 2024

11.4.7 HealthCaps India Dry Powder Inhalation Capsules Sales by Geographic Area in 2024

11.4.8 HealthCaps India Dry Powder Inhalation Capsules SWOT Analysis

11.4.9 HealthCaps India Recent Developments

11.5 Cipla

11.5.1 Cipla Corporation Information

11.5.2 Cipla Business Overview

11.5.3 Cipla Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.5.4 Cipla Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Cipla Dry Powder Inhalation Capsules Sales by Product in 2024

11.5.6 Cipla Dry Powder Inhalation Capsules Sales by Application in 2024

11.5.7 Cipla Dry Powder Inhalation Capsules Sales by Geographic Area in 2024

11.5.8 Cipla Dry Powder Inhalation Capsules SWOT Analysis

11.5.9 Cipla Recent Developments

11.6 Boehringer Ingelheim GmbH

11.6.1 Boehringer Ingelheim GmbH Corporation Information

11.6.2 Boehringer Ingelheim GmbH Business Overview

11.6.3 Boehringer Ingelheim GmbH Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.6.4 Boehringer Ingelheim GmbH Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Boehringer Ingelheim GmbH Recent Developments

11.7 Elpen S.A.

11.7.1 Elpen S.A. Corporation Information

11.7.2 Elpen S.A. Business Overview

11.7.3 Elpen S.A. Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.7.4 Elpen S.A. Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Elpen S.A. Recent Developments

11.8 Vectura Group Plc

11.8.1 Vectura Group Plc Corporation Information

11.8.2 Vectura Group Plc Business Overview

11.8.3 Vectura Group Plc Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.8.4 Vectura Group Plc Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Vectura Group Plc Recent Developments

11.9 CHIESI Farmaceutici S.p.A.

11.9.1 CHIESI Farmaceutici S.p.A. Corporation Information

11.9.2 CHIESI Farmaceutici S.p.A. Business Overview

11.9.3 CHIESI Farmaceutici S.p.A. Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.9.4 CHIESI Farmaceutici S.p.A. Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 CHIESI Farmaceutici S.p.A. Recent Developments

11.10 AstraZeneca Plc

11.10.1 AstraZeneca Plc Corporation Information

11.10.2 AstraZeneca Plc Business Overview

11.10.3 AstraZeneca Plc Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.10.4 AstraZeneca Plc Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 AstraZeneca Plc Recent Developments

11.11 Novartis

11.11.1 Novartis Corporation Information

11.11.2 Novartis Business Overview

11.11.3 Novartis Dry Powder Inhalation Capsules Product Models, Descriptions and Specifications

11.11.4 Novartis Dry Powder Inhalation Capsules Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Novartis Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Dry Powder Inhalation Capsules Industry Chain

12.2 Dry Powder Inhalation Capsules Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Dry Powder Inhalation Capsules Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Dry Powder Inhalation Capsules Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Dry Powder Inhalation Capsules Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Dry Powder Inhalation Capsules Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Capsugel (Lonza)

ACG

Qualicaps

HealthCaps India

Cipla Ltd

Boehringer Ingelheim GmbH

ELPEN

Vectura Group plc

Chiesi Farmaceutici

Astrazeneca plc

Novartis

List of Tables

Table 1. Global Dry Powder Inhalation Capsules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Dry Powder Inhalation Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Dry Powder Inhalation Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Dry Powder Inhalation Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Dry Powder Inhalation Capsules Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Dry Powder Inhalation Capsules Sales by Region (2020-2025) & (K Units)

Table 8. Global Dry Powder Inhalation Capsules Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Dry Powder Inhalation Capsules Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Dry Powder Inhalation Capsules Sales Share by Manufacturers (2020-2025)

Table 12. Global Dry Powder Inhalation Capsules Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Dry Powder Inhalation Capsules Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Dry Powder Inhalation Capsules by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Capsules as of 2024)

Table 16. Global Dry Powder Inhalation Capsules Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Dry Powder Inhalation Capsules Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Dry Powder Inhalation Capsules Manufacturing Base and Headquarters

Table 19. Global Dry Powder Inhalation Capsules Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Dry Powder Inhalation Capsules Sales by Type (2020-2025) & (K Units)

Table 23. Global Dry Powder Inhalation Capsules Sales by Type (2026-2031) & (K Units)

Table 24. Global Dry Powder Inhalation Capsules Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Dry Powder Inhalation Capsules Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Dry Powder Inhalation Capsules ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Dry Powder Inhalation Capsules Sales by Application (2020-2025) & (K Units)

Table 29. Global Dry Powder Inhalation Capsules Sales by Application (2026-2031) & (K Units)

Table 30. Dry Powder Inhalation Capsules High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Dry Powder Inhalation Capsules Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Dry Powder Inhalation Capsules Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Dry Powder Inhalation Capsules ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Dry Powder Inhalation Capsules Growth Accelerators and Market Barriers

Table 37. North America Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Dry Powder Inhalation Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Dry Powder Inhalation Capsules Growth Accelerators and Market Barriers

Table 40. Europe Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Dry Powder Inhalation Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Dry Powder Inhalation Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Dry Powder Inhalation Capsules Growth Accelerators and Market Barriers

Table 45. Southeast Asia Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Dry Powder Inhalation Capsules Investment Opportunities and Key Challenges

Table 47. Central and South America Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Dry Powder Inhalation Capsules Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Dry Powder Inhalation Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Capsugel (Lonza) Corporation Information

Table 51. Capsugel (Lonza) Description and Major Businesses

Table 52. Capsugel (Lonza) Product Models, Descriptions and Specifications

Table 53. Capsugel (Lonza) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Capsugel (Lonza) Sales Value Proportion by Product in 2024

Table 55. Capsugel (Lonza) Sales Value Proportion by Application in 2024

Table 56. Capsugel (Lonza) Sales Value Proportion by Geographic Area in 2024

Table 57. Capsugel (Lonza) Dry Powder Inhalation Capsules SWOT Analysis

Table 58. Capsugel (Lonza) Recent Developments

Table 59. ACG Corporation Information

Table 60. ACG Description and Major Businesses

Table 61. ACG Product Models, Descriptions and Specifications

Table 62. ACG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. ACG Sales Value Proportion by Product in 2024

Table 64. ACG Sales Value Proportion by Application in 2024

Table 65. ACG Sales Value Proportion by Geographic Area in 2024

Table 66. ACG Dry Powder Inhalation Capsules SWOT Analysis

Table 67. ACG Recent Developments

Table 68. Qualicaps Corporation Information

Table 69. Qualicaps Description and Major Businesses

Table 70. Qualicaps Product Models, Descriptions and Specifications

Table 71. Qualicaps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Qualicaps Sales Value Proportion by Product in 2024

Table 73. Qualicaps Sales Value Proportion by Application in 2024

Table 74. Qualicaps Sales Value Proportion by Geographic Area in 2024

Table 75. Qualicaps Dry Powder Inhalation Capsules SWOT Analysis

Table 76. Qualicaps Recent Developments

Table 77. HealthCaps India Corporation Information

Table 78. HealthCaps India Description and Major Businesses

Table 79. HealthCaps India Product Models, Descriptions and Specifications

Table 80. HealthCaps India Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. HealthCaps India Sales Value Proportion by Product in 2024

Table 82. HealthCaps India Sales Value Proportion by Application in 2024

Table 83. HealthCaps India Sales Value Proportion by Geographic Area in 2024

Table 84. HealthCaps India Dry Powder Inhalation Capsules SWOT Analysis

Table 85. HealthCaps India Recent Developments

Table 86. Cipla Corporation Information

Table 87. Cipla Description and Major Businesses

Table 88. Cipla Product Models, Descriptions and Specifications

Table 89. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Cipla Sales Value Proportion by Product in 2024

Table 91. Cipla Sales Value Proportion by Application in 2024

Table 92. Cipla Sales Value Proportion by Geographic Area in 2024

Table 93. Cipla Dry Powder Inhalation Capsules SWOT Analysis

Table 94. Cipla Recent Developments

Table 95. Boehringer Ingelheim GmbH Corporation Information

Table 96. Boehringer Ingelheim GmbH Description and Major Businesses

Table 97. Boehringer Ingelheim GmbH Product Models, Descriptions and Specifications

Table 98. Boehringer Ingelheim GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Boehringer Ingelheim GmbH Recent Developments

Table 100. Elpen S.A. Corporation Information

Table 101. Elpen S.A. Description and Major Businesses

Table 102. Elpen S.A. Product Models, Descriptions and Specifications

Table 103. Elpen S.A. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Elpen S.A. Recent Developments

Table 105. Vectura Group Plc Corporation Information

Table 106. Vectura Group Plc Description and Major Businesses

Table 107. Vectura Group Plc Product Models, Descriptions and Specifications

Table 108. Vectura Group Plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Vectura Group Plc Recent Developments

Table 110. CHIESI Farmaceutici S.p.A. Corporation Information

Table 111. CHIESI Farmaceutici S.p.A. Description and Major Businesses

Table 112. CHIESI Farmaceutici S.p.A. Product Models, Descriptions and Specifications

Table 113. CHIESI Farmaceutici S.p.A. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. CHIESI Farmaceutici S.p.A. Recent Developments

Table 115. AstraZeneca Plc Corporation Information

Table 116. AstraZeneca Plc Description and Major Businesses

Table 117. AstraZeneca Plc Product Models, Descriptions and Specifications

Table 118. AstraZeneca Plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. AstraZeneca Plc Recent Developments

Table 120. Novartis Corporation Information

Table 121. Novartis Description and Major Businesses

Table 122. Novartis Product Models, Descriptions and Specifications

Table 123. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Novartis Recent Developments

Table 125. Key Raw Materials Distribution

Table 126. Raw Materials Key Suppliers

Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 128. Milestones in Production Technology Evolution

Table 129. Distributors List

Table 130. Market Trends and Market Evolution

Table 131. Market Drivers and Opportunities

Table 132. Market Challenges, Risks, and Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Dry Powder Inhalation Capsules Product Picture

Figure 2. Global Dry Powder Inhalation Capsules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Gelatin Capsules Product Picture

Figure 4. Hypromellose Capsules Product Picture

Figure 5. Global Dry Powder Inhalation Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Asthma Treatment

Figure 7. COPD Management

Figure 8. Others

Figure 9. Dry Powder Inhalation Capsules Report Years Considered

Figure 10. Global Dry Powder Inhalation Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 12. Global Dry Powder Inhalation Capsules Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Dry Powder Inhalation Capsules Revenue Market Share by Region (2020-2031)

Figure 14. Global Dry Powder Inhalation Capsules Sales (2020-2031) & (K Units)

Figure 15. Global Dry Powder Inhalation Capsules Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Dry Powder Inhalation Capsules Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Dry Powder Inhalation Capsules Sales Volume Market Share in 2024

Figure 18. Global Dry Powder Inhalation Capsules Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Gelatin Capsules Revenue Market Share by Manufacturer in 2024

Figure 21. Hypromellose Capsules Revenue Market Share by Manufacturer in 2024

Figure 22. Global Dry Powder Inhalation Capsules Sales Market Share by Type (2020-2031)

Figure 23. Global Dry Powder Inhalation Capsules Revenue Market Share by Type (2020-2031)

Figure 24. Global Dry Powder Inhalation Capsules Sales Market Share by Application (2020-2031)

Figure 25. Global Dry Powder Inhalation Capsules Revenue Market Share by Application (2020-2031)

Figure 26. North America Dry Powder Inhalation Capsules Sales YoY (2020-2031) & (K Units)

Figure 27. North America Dry Powder Inhalation Capsules Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Dry Powder Inhalation Capsules Sales Revenue (US$ Million) in 2024

Figure 29. North America Dry Powder Inhalation Capsules Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Dry Powder Inhalation Capsules Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Dry Powder Inhalation Capsules Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Dry Powder Inhalation Capsules Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Dry Powder Inhalation Capsules Sales Revenue (US$ Million) in 2024

Figure 39. Europe Dry Powder Inhalation Capsules Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Dry Powder Inhalation Capsules Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 44. France Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Dry Powder Inhalation Capsules Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Dry Powder Inhalation Capsules Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Dry Powder Inhalation Capsules Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Dry Powder Inhalation Capsules Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Dry Powder Inhalation Capsules Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 59. India Dry Powder Inhalation Capsules Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Dry Powder Inhalation Capsules Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Dry Powder Inhalation Capsules Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Dry Powder Inhalation Capsules Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Dry Powder Inhalation Capsules Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Dry Powder Inhalation Capsules Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Dry Powder Inhalation Capsules Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Dry Powder Inhalation Capsules Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Dry Powder Inhalation Capsules Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Dry Powder Inhalation Capsules Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Dry Powder Inhalation Capsules Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Dry Powder Inhalation Capsules Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Dry Powder Inhalation Capsules Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Dry Powder Inhalation Capsules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Dry Powder Inhalation Capsules Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Dry Powder Inhalation Capsules Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Dry Powder Inhalation Capsules Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Dry Powder Inhalation Capsules Revenue (2020-2025) & (US$ Million)

Figure 80. Dry Powder Inhalation Capsules Industry Chain Mapping

Figure 81. Regional Dry Powder Inhalation Capsules Manufacturing Base Distribution (%)

Figure 82. Global Dry Powder Inhalation Capsules Production Market Share by Region (2020-2031)

Figure 83. Dry Powder Inhalation Capsules Production Process

Figure 84. Regional Dry Powder Inhalation Capsules Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Dry Powder Inhalation Device Market Research Report 2024

Global DPI Capsules Packaging Market Research Report 2025

Dry Powder Inhaler Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adult Dry Powder Inhalers Market Research Report 2024

Global Children Dry Powder Inhalers Market Research Report 2024

Global COPD and Asthma Drug Devices Market Insights Forecast to 2030

Global Multi Dose Dry Powder Inhaler Device Market Research Report 2025

Global Inhalation Drug Delivery Devices Market Research Report 2024

Global Single Dose Dry Powder Inhaler Device Market Research Report 2025

Global Inhaler Devices for Respiratory Medicines Market Research Report 2024

Global Dry Powder Inhalation Delivery System Market Research Report 2024

Global Inhalation Capsules Market Insights Forecast to 2030

Global Asthma Inhalation Formulation Market Research Report 2024

Global Corticosteroids Inhalation Formulation Market Research Report 2024

Global Capsule based Inhalers Market Insights Forecast to 2030

Global Empty Capsule for Inhalation Market Research Report 2025

Global Breath actuated Inhaler Market Research Report 2025

Global Dry Powder Inhalation Excipients Market Research Report 2024

Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions